Pharmaceutical Analytical Testing Outsourcing Market

Pharmaceutical Analytical Testing Outsourcing Market Size by Product Type (Active Pharmaceutical Ingredients, Raw Materials, and Finished Products), Service Type [Stability Testing (Accelerated Stability Testing, Photostability Testing, Drug Substance, and Stability Indicating Method Validation), Bioanalytical (Clinical and Non-clinical), Method Development and Validation (Technical Consulting, Extractable and Leachable, Impurity Method and Others) and Others], End-users (Biopharmaceutical Companies, Contract Research Organization, and Pharmaceutical Companies), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2022 to 2030

Base Year: 2021 Historical Data: 2019-20
  • Report ID: TBI-12953
  • Published Date: Sep, 2022
  • Pages: 235
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global pharmaceutical analytical testing outsourcing market is expected to reach USD 15.85 billion by 2030, at a CAGR of 8.02% from 2022 to 2030. The driving factors include a rising focus on quality control of drugs, rising awareness of outsourcing, and the presence of regulatory authorities. Analytical testing outsourcing is gaining popularity in developed and developing regions, especially among mid and small-scale pharmaceutical companies. Outsourcing has helped these companies to save their limited resources and improve the process. The testing of pharmaceutical products is necessary to avoid casualties and minimize side effects.

Pharmaceutical analytical testing outsourcing covers all product testing requirements for a pharmaceutical or biotech company. Pharmaceutical analytical testing refers to quantifying and identifying components in pharmaceutical drugs and solutions. The pharmaceuticals and biotech companies are outsourcing the drug analytical testing process owing to the increasing competition in the market. These companies have found that outsourcing has many benefits compared to the in-house testing of drugs. It saves up manufacturing costs and also enables the deployment of advanced technologies. Outsourcing helps to integrate the applications of artificial intelligence in the analytical testing of drugs. It also allows the players to manufacture more specialized drugs.

Pharmaceutical Analytical Testing Outsourcing Market

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:

Awareness regarding coverages of pharmaceutical analytical testing outsourcing

Pharma and biotech companies seeking external development expertise and labor support for their potential compounds have changed as pharmaceutical analytical testing outsourcing consolidates at breakneck speed. Clinical trial outsourcing options are becoming more popular as industry rules change, incentives to minimize drug development costs grow, and demand for innovative cures grows. Many firms have reconsidered their whole research strategy and reassessed insourcing, including conventional staffing. Pharmaceutical analytical testing outsourcing companies are essential participants in clinical research because they have the expertise and capabilities required for a clinical study's proper development. They benefit from pharmaceutical, contract research organizations, and biotech companies because they save their burden while assuring trial quality and compliance with national and international standards. At the same time, several pharmaceutical analytical testing outsourcing organizations offer cutting-edge technology tools to improve study process efficiency, resulting in resource savings.

Restraints:

Lack of skilled professionals

The availability of skilled professionals determines the quality of outsourcing testing. Due to the lack of availability of experienced professionals, the market growth is restraining. The analytical testing requires high precision during the whole process to minimize the presence of any impurities.

Opportunities:

Increasing research and development activities

Research and development is an investment in knowledge and technology for pharmaceutical and biotechnology companies. Pharmaceutical companies can spend much time and money on drug creation, research, process improvement, and innovation. Numerous industry participants reported record sales, primarily due to strong growth in emerging nations like the USA, Japan, Germany, China, India, and the U.K., as well as rising government spending on pharmaceutical R&D in developing countries, increasing life science R&D expenditure, progress in the drug discovery and clinical diagnostics fields, technological advancements, emerging applications, growing geriatric populations, rising prevalence of chronic diseases, and shifting demographics. Research breakthroughs in the biological sciences and technological improvements in the analytical testing of drugs have contributed to the constant expansion of the biotechnology sector. Due to this, high-end research projects demand high-quality equipment with high throughput capacity, further stimulating the pharmaceutical analytical testing outsourcing market.

Challenges:

Regulations by concerned authorities

Pharmaceutical analytical testing must be passed through state regulations and launched in the market. Pharmaceutical analytical testing outsourcing providers are subject to the legal laws of different countries. Legal considerations are an integral part of pharmaceutical analytical testing outsourcing. These are required to be written by constituted firms. Thus, these stringent regulations act as a challenge to market growth.

Segmentation Analysis:

The global pharmaceutical analytical testing outsourcing market has been segmented based on product type, service type, end-users, and region.

The product type segment is divided into active pharmaceutical ingredients, raw materials, and finished products. Out of the three main segments, active pharmaceutical ingredients accounted for 41.10% of the market share in 2021. Active pharmaceutical ingredients are the main components of drugs as they are responsible for the patient's recovery. The quality testing of active pharmaceutical ingredients is necessary to remove impurities. Analytical testing has increased the scope of application for active pharmaceutical ingredients, as when APIs are tested analytically, they can be used for several drug batches.

The service type segment is divided into stability testing, bioanalytical, method development and validation, and others. The stability testing is further segmented into accelerated stability testing, photostability testing, drug substance, and stability indicating method validation. The bioanalytical segment is further segmented into clinical and non-clinical. The method development and validation segment consist of technical consulting, extractable and leachable, impurity method, and others. The stability testing segment held the highest share of around 37.07% in 2021. Stability testing is an integral part of pharmaceutical manufacturing practices as it determines the storage conditions of a drug. Stability testing is necessary for keeping drugs effective and safe in certain situations.

The end-user segment is divided into biopharmaceutical companies, contract research organizations, and pharmaceutical companies. Of these end-users, pharmaceutical companies held the highest share of around 46.11% in 2021. Pharmaceutical products are subjected to several clinical trials that focus on testing different attributes of a drug. Many mid and small-size pharmaceutical companies lack the facility of in-house testing labs. Thus, outsourcing pharmaceutical analytical testing enables these companies to focus on core manufacturing.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North American region emerged as the largest market for the global pharmaceutical analytical testing outsourcing market, with a 41.92% market revenue share in 2021.

  • In 2021, the pharmaceutical analytical testing outsourcing market was dominated by North America because of a significant number of players present in the region. The other contributing factors include rising demand from small and mid-scale pharmaceutical companies and increasing production of drugs, witnessing a rise in the prevalence of chronic diseases, and constant support from the government agencies of the U.S. and Canada.
  • In addition, the Asia-Pacific region will have the fastest CAGR in the market. The rising demand for outsourcing from pharmaceutical giants and increasing focus on quality control in countries like Japan and India will benefit the region's market size.

North America Region Pharmaceutical Analytical Testing Outsourcing Market Share in 2021 - 41.92%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

In December 2021, a significant player named SGS SA took over the pharmaceutical research and development organization Quay Pharma. The objective of this acquisition was to expand the former's analytical testing capability.

List of Key Market Players:

  • Labcorp
  • SGS SA
  • Pace Analytical Services, Inc
  • Eurofins Scientific
  • Intertek Group Plc
  • WuXi AppTec
  • PPD Inc
  • Charles River Laboratories
  • Boston Analytical
  • West Pharmaceutical Services
  • Toxikon, Inc.
  • Exova
  • Ajinomoto Bio-Pharma
  • Source BioScienc
  • Gateway Analytical
  • Catalent, Inc
  • Alcami Corporation
  • Recro
  • AptarGroup, Inc.
  • Aztech Sciences Inc.

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities
  • Consulting And Research Firm

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2021 USD 7.92 billion
Market size value in 2030 USD 15.85 billion
CAGR (2022 to 2030) 8.11%
Historical data 2019-2020
Base Year 2021
Forecast 2022-2030
Segments The based-on application, product type, form, buyer, distribution channel
Regional Segments North America, Asia Pacific, Europe, Latin America, Middle East and Africa

Frequesntly Asked Questions

As per The Brainy Insights, the size of the pharmaceutical analytical testing outsourcing market was valued USD 7.92 billion in 2021 to USD 15.85 billion by 2030.

Global pharmaceutical analytical testing outsourcing market is growing at a CAGR of 8.02% during the forecast period 2022-2030.

The market's growth will be influenced by the rising preference for outsourcing of analytical testing by medium and small-size companies.

The lack of skilled professionals present in the analytical testing department could hamper the market growth.

The rising focus on research and development of drugs and increase in number of regulatory requirements provide significant opportunities to the market.

1. Introduction
    1.1. Objective of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Product Type
          4.3.2. Market Attractiveness Analysis By Service Type
          4.3.3. Market Attractiveness Analysis By End-users
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing demand for outsourcing of analytical testing among pharmaceutical companies
    5.3. Restraints
          5.3.1. Lack of skilled professionals
    5.4. Opportunities
          5.4.1. Increasing focus on research and development of pharmaceutical products
    5.5. Challenges
          5.5.1. Regulations by concerned authorities

6. Global Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecast, By Product Type
    6.1. Segment Overview
    6.2. Active Pharmaceutical Ingredients
    6.3. Raw Materials
    6.4. Finished Products

7. Global Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecast, By Service Type
    7.1. Segment Overview
    7.2. Stability Testing
          7.2.1. Accelerated Stability Testing
          7.2.2. Photostability Testing
          7.2.3. Drug Substance
          7.2.4. Stability Indicating Method Validation
    7.3. Bioanalytical
          7.3.1. Clinical
          7.3.2. Non-clinical
    7.4. Method Development and Validation
          7.4.1. Technical Consulting
          7.4.2. Extractable and Leachable
          7.4.3. Impurity Method
          7.4.4. Others
    7.5. Others

8. Global Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecast, By End-users
    8.1. Segment Overview
    8.2. Biopharmaceutical Companies
    8.3. Contract Research Organization
    8.4. Pharmaceutical Companies

9. Global Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Pharmaceutical Analytical Testing Outsourcing Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in the Pharmaceutical Analytical Testing Outsourcing Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Labcorp
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. SGS SA
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Pace Analytical Services, Inc
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Eurofins Scientific
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Intertek Group Plc
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. WuXi AppTec
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. PPD Inc
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Charles River Laboratories
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Boston Analytical
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. West Pharmaceutical Services
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
    11.11. Toxikon, Inc.
          11.11.1. Business Overview
          11.11.2. Company Snapshot
          11.11.3. Company Market Share Analysis
          11.11.4. Company Product Portfolio
          11.11.5. Recent Developments
          11.11.6. SWOT Analysis
    11.12. Exova
          11.12.1. Business Overview
          11.12.2. Company Snapshot
          11.12.3. Company Market Share Analysis
          11.12.4. Company Product Portfolio
          11.12.5. Recent Developments
          11.12.6. SWOT Analysis
    11.13. Ajinomoto Bio-Pharma
          11.13.1. Business Overview
          11.13.2. Company Snapshot
          11.13.3. Company Market Share Analysis
          11.13.4. Company Product Portfolio
          11.13.5. Recent Developments
          11.13.6. SWOT Analysis
    11.14. Source BioScienc
          11.14.1. Business Overview
          11.14.2. Company Snapshot
          11.14.3. Company Market Share Analysis
          11.14.4. Company Product Portfolio
          11.14.5. Recent Developments
          11.14.6. SWOT Analysis
    11.15. Gateway Analytical
          11.15.1. Business Overview
          11.15.2. Company Snapshot
          11.15.3. Company Market Share Analysis
          11.15.4. Company Product Portfolio
          11.15.5. Recent Developments
          11.15.6. SWOT Analysis
    11.16. Catalent, Inc
          11.16.1. Business Overview
          11.16.2. Company Snapshot
          11.16.3. Company Market Share Analysis
          11.16.4. Company Product Portfolio
          11.16.5. Recent Developments
          11.16.6. SWOT Analysis
    11.17. Alcami Corporation
          11.17.1. Business Overview
          11.17.2. Company Snapshot
          11.17.3. Company Market Share Analysis
          11.17.4. Company Product Portfolio
          11.17.5. Recent Developments
          11.17.6. SWOT Analysis
    11.18. Recro
          11.18.1. Business Overview
          11.18.2. Company Snapshot
          11.18.3. Company Market Share Analysis
          11.18.4. Company Product Portfolio
          11.18.5. Recent Developments
          11.18.6. SWOT Analysis
    11.19. AptarGroup, Inc.
          11.19.1. Business Overview
          11.19.2. Company Snapshot
          11.19.3. Company Market Share Analysis
          11.19.4. Company Product Portfolio
          11.19.5. Recent Developments
          11.19.6. SWOT Analysis
    11.20. Aztech Sciences Inc
          11.20.1. Business Overview
          11.20.2. Company Snapshot
          11.20.3. Company Market Share Analysis
          11.20.4. Company Product Portfolio
          11.20.5. Recent Developments
          11.20.6. SWOT Analysis

List of Table

1. Global Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

2. Global Active Pharmaceutical Ingredients, Pharmaceutical Analytical Testing Outsourcing Market, By Region, 2019-2030 (USD Billion) 

3. Global Raw Materials, Pharmaceutical Analytical Testing Outsourcing Market, By Region, 2019-2030 (USD Billion) 

4. Global Finished Products, Pharmaceutical Analytical Testing Outsourcing Market, By Region, 2019-2030 (USD Billion) 

5. Global Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

6. Global Stability Testing, Pharmaceutical Analytical Testing Outsourcing Market, By Region, 2019-2030 (USD Billion) 

7. Global Bioanalytical, Pharmaceutical Analytical Testing Outsourcing Market, By Region, 2019-2030 (USD Billion) 

8. Global Method Development and Validation, Pharmaceutical Analytical Testing Outsourcing Market, By Region, 2019-2030 (USD Billion) 

9. Global Others, Pharmaceutical Analytical Testing Outsourcing Market, By Region, 2019-2030 (USD Billion) 

10. Global Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

11. Global Biopharmaceutical Companies, Pharmaceutical Analytical Testing Outsourcing Market, By Region, 2019-2030 (USD Billion) 

12. Global Contract Research Organization, Pharmaceutical Analytical Testing Outsourcing Market, By Region, 2019-2030 (USD Billion)

13. Global Pharmaceutical Companies, Pharmaceutical Analytical Testing Outsourcing Market, By Region, 2019-2030 (USD Billion) 

14. Global Pharmaceutical Analytical Testing Outsourcing Market, By Region, 2019-2030 (USD Billion) 

15. North America Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

16. North America Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

17. North America Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

18. U.S. Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

19. U.S. Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

20. U.S. Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

21. Canada Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

22. Canada Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

23. Canada Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

24. Mexico Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

25. Mexico Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

26. Mexico Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion)

27. Europe Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

28. Europe Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

29. Europe Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion)

30. Germany Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

31. Germany Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

32. Germany Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

33. France Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

34. France Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

35. France Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion)

36. U.K. Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

37. U.K. Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

38. U.K. Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion)

39. Italy Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

40. Italy Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

41. Italy Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion)

42. Spain Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

43. Spain Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

44. Spain Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

45. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

46. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

47. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

48. Japan Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

49. Japan Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

50. Japan Pharmaceutical Analytical Testing Outsourcing Market, By End-users 2019-2030 (USD Billion)

51. China Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

52. China Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

53. China Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion)

54. India Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

55. India Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

56. India Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

57. South America Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

58. South America Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

59. South America Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

60. Brazil Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

61. Brazil Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

62. Brazil Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

63. Middle East and Africa Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

64. Middle East and Africa Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

65. Middle East and Africa Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion)

66. UAE Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

67. UAE Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

68. UAE Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

69. South Africa Pharmaceutical Analytical Testing Outsourcing Market, By Product Type, 2019-2030 (USD Billion) 

70. South Africa Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, 2019-2030 (USD Billion) 

71. South Africa Pharmaceutical Analytical Testing Outsourcing Market, By End-users, 2019-2030 (USD Billion) 

List of Figures 

1. Global Pharmaceutical Analytical Testing Outsourcing Market Segmentation

2. Pharmaceutical Analytical Testing Outsourcing Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Pharmaceutical Analytical Testing Outsourcing Market Attractiveness Analysis By Product Type

9. Global Pharmaceutical Analytical Testing Outsourcing Market Attractiveness Analysis By Service Type

10. Global Pharmaceutical Analytical Testing Outsourcing Market Attractiveness Analysis By End-users

11. Global Pharmaceutical Analytical Testing Outsourcing Market Attractiveness Analysis By Region

12. Global Pharmaceutical Analytical Testing Outsourcing Market: Dynamics

13. Global Pharmaceutical Analytical Testing Outsourcing Market Share by Product Type (2022 & 2030)

14. Global Pharmaceutical Analytical Testing Outsourcing Market Share by Service Type (2022 & 2030)

15. Global Pharmaceutical Analytical Testing Outsourcing Market Share by End-users (2022 & 2030)

16. Global Pharmaceutical Analytical Testing Outsourcing Market Share by Regions (2022 & 2030)

17. Global Pharmaceutical Analytical Testing Outsourcing Market Share by Company (2021)

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the global pharmaceutical analytical testing outsourcing market based on below mentioned segments:

Global Pharmaceutical Analytical Testing Outsourcing Market by Product Type:

  • Active Pharmaceutical Ingredients
  • Raw Materials
  • Finished Products

Global Pharmaceutical Analytical Testing Outsourcing Market by Service Type:

  • Stability Testing
    • Accelerated Stability Testing
    • Photostability Testing
    • Drug Substance
    • Stability Indicating Method Validation
  • Bioanalytical
    • Clinical
    • Non-clinical
  • Method Development and Validation
    • Technical Consulting
    • Extractable and Leachable
    • Impurity Method
    • Others
  • Others

Global Pharmaceutical Analytical Testing Outsourcing Market by End-users:

  • Biopharmaceutical Companies
  • Contract Research Organization
  • Pharmaceutical Companies

Global Pharmaceutical Analytical Testing Outsourcing Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date